✦ LIBER ✦

P-311 Interim analysis of phase II randomized trial of azacitidine versus support treatment in patients with low-risk myelodysplastic syndrome

✍ Scribed by Sanchez-Garcia, J.; Falantes, J.; Medina, A.; Hernandez-Mohedo, F.; Torres-Sabariego, A.; Hermosin, L.; Bailen, A.; Sole, M.; Casaño, J.; Calderon, C.; Vahi, M.; Serrano, J.

Book ID: 122774817
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 72 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/S0145-2126(13)70358-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-320 ARCADE (20090160): A randomized co

P-320 ARCADE (20090160): A randomized controlled trial of darbepoetin alpha in anemic patients with low or intermediate-1 risk myelodysplastic syndrome (MDS)

✍ Gasai, E.; Pan, C.; Tankersley, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 120 KB

P-706 Randomized phase II study of seque

P-706 Randomized phase II study of sequetial versus concurrent chemoradiotherapy (CRT) in poor risk patients with inoperable stage III non-small cell lung cancer (NSCLC): Interim analysis

✍ Cardenal, F.; Arnaiz, M.; Valencia, J.; Casas, F.; Perez, A.; Perez, J.; Chus, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

A non-randomised dose-escalating phase I

A non-randomised dose-escalating phase II study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes: the Thal-SMD-2000 trial of the Groupe Français des Myélodysplasies

✍ Didier Bouscary; Laurence Legros; Micheline Tulliez; Stéphanie Dubois; Béatrice 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB

740 POSTER Fluorouracil, leucovorin and

740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 302 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

251 A randomized phase II trial of neoad

251 A randomized phase II trial of neoadjuvant chemotherapy followed by surgery versus surgery alone in patients with stage I, II and IIIA (N0) non-small cell lung cancer. Preliminary analysis

✍ Splinter, A.W.; Smit, E.; Postmus, P.; Kho, G.S.; Maat, A.P.W.M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB